-- Robert Preidt
TUESDAY, Aug. 6 (HealthDay News) -- The U.S> Food and Drug
Administration has approved shipping of the first vaccine to
protect against four strains of seasonal flu.
The GlaxoSmithKline vaccine, called Fluarix Quadrivalent, was
approved by the FDA last December for use in adults and children
aged 3 and older. But approved flu vaccines still have to be
certified by the FDA each season before they can be shipped to
health care providers.
Viruses that cause seasonal flu are classified as A or B
strains. Most current flu vaccines provide protection against three
strains: the two A strains most common in people, and the B strain
expected to be predominant in an upcoming flu season.
This is the first season that vaccines protecting against more
than three flu strains will be available.
"Trivalent [three-strain] influenza vaccines offer important protection against influenza. But since the late 1980s, scientists noted that two B virus lineage strains circulate to varying degrees each year, and it's difficult to predict which one will cause the most illness in a particular influenza season. Fluarix Quadrivalent addresses this by protecting against both B strains," Dr. Leonard Friedland, vice president of scientific affairs and public policy at GlaxoSmithKline Vaccines, North America, said in a company news release.
The U.S. Centers for Disease Control and Prevention placed the
largest order for Fluarix Quadrivalent -- more than 4 million doses
-- and will distribute those doses to state and local health care
GlaxoSmithKline estimates it will provide up to 10 million doses
of quadrivalent influenza vaccine in the United States, and 22
million to 24 million doses of influenza vaccine overall. Fluarix
Quadrivalent also is approved in Germany and the United
In clinical trials of the new vaccine, the most common negative
side effects in adults were pain at the injection site, muscle
aches, headaches and fatigue. Negative side effects among children
included: pain at the injection site, redness and swelling,
drowsiness, irritability, loss of appetite, fatigue, muscle aches,
headache and gastrointestinal symptoms.
The U.S. Centers for Disease Control and Prevention has more
seasonal flu vaccine.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.